pharmaphorum
JUNE 14, 2021
In this episode of our Health Innovators series, Paul Tunnah interviews Graeme Duncan, CEO of specialty pharmaceutical company Advanz Pharma. Graeme discusses his career in the life sciences industry and how Advanz Pharma positions itself as the go-to partner for companies commercialising complex medicines in Europe.
pharmaphorum
NOVEMBER 26, 2020
Since the start of the year, pharmaceutical companies have been riding a rollercoaster of challenges. As the industry moves from a face-to-face to digital communication model, it needs a change of mindset, he adds. “A Pawlu describes a “perfect storm” as the various strands came together to threaten supply chains.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JANUARY 25, 2024
7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 The responsibility of printing paper leaflets is currently a key regulatory obligation for pharmaceutical companies. Article 63 EMA (29 January 2020).
pharmaphorum
JULY 14, 2021
He was referring to his business’ share of misconduct related fines that, between 2009 and 2017, topped $342 billion across the US and Europe. It’s killing us.” As the sector looks to maintain its momentum, it must be wary that positive messaging and increased scrutiny does not end up as a recipe for a hard fall.
Pharma Marketing Network
JUNE 11, 2020
So, this was back in 2009, and I hosted a Halloween party at my house, and I decided to dress up as Hunter S. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. So, I didn’t look so bad.
pharmaphorum
MARCH 30, 2021
Online communication now seems the natural way to get things done, and the sky’s the limit for what we can achieve for our rare disease patients if we continue to drive this innovation and this openness.”. Connect with Dr Tunnah at [link] or [link].
Pharmaceutical Technology
FEBRUARY 1, 2023
RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.
Expert insights. Personalized for you.
52 
Let's personalize your content